Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2009;54:964-965
Published online before print September 21, 2009, doi: 10.1161/HYPERTENSIONAHA.109.137984
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
54/5/964    most recent
HYPERTENSIONAHA.109.137984v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Brandes, R. P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brandes, R. P.
Related Collections
Right arrow Other etiology
Right arrow Oxidant stress
Right arrow Other Vascular biology
Right arrow Other Research
Right arrowRelated Article

(Hypertension. 2009;54:964.)
© 2009 American Heart Association, Inc.


Editorial Commentaries

A New PIXel in the Puzzle

How Increased Vascular Pressure Induces Oxidative Stress

Ralf P. Brandes

Correspondence to Ralf P. Brandes, Institut für Kardiovaskuläre Physiologie, Johann Wolfgang Goethe-Universität, Theodor-Stern-Kai 7, D-60596 Frankfurt am Main, Germany. E-mail r.brandes@em.unifrankfurt.de


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Hypertension is a clinical situation associated with endothelial dysfunction and increased vascular reactive oxygen species (ROS) formation. The observations that antioxidants, such as Tempol or apocynin, lower the blood pressure in spontaneously hypertensive rats gave rise to the concept that ROS essentially contribute to hypertension. Recent work, however, has sharpened this view, and it is now clear that the underlying mechanism of ROS-induced hypertension may not be endothelial dysfunction but rather an ROS-dependent modulation of the sympathetic drive,1 the kidney, and potentially alterations in the immune system.2 Despite these findings, hypertension has been consistently linked to increased ROS formation in the vascular system. It is, therefore, plausible that ROS are not necessarily the cause but potentially the consequence of hypertension. This notion certainly does not exclude that ROS are involved in the pathogenesis of specific aspects of hypertension, such as the development of fibrosis.

In keeping with the concept of hypertension-induced ROS formation, it was noted previously that distension of a vessel with an oversized balloon acutely increases ROS formation.3 Moreover, acute elevation of pressure from 80 to 160 mm Hg enhances the ROS formation and induces an ROS-dependent attenuation of the endothelium-dependent relaxation in isolated rat femoral arteries.4 Moreover, even in chronic models of isolated hypertension, such as aortic banding, the ROS formation was consistently higher in the hypertensive rather than in the normotensive part.

There is, however, uncertainty regarding the enzymatic sources of ROS, and a contribution of mitochondria, endothelial NO synthase uncoupling, and NADPH oxidases has been . . . [Full Text of this Article]


Related Article:

Pressure-Induced Vascular Oxidative Stress Is Mediated Through Activation of Integrin-Linked Kinase 1/βPIX/Rac-1 Pathway
Carmine Vecchione, Daniela Carnevale, Alba Di Pardo, Maria Teresa Gentile, Antonio Damato, Germana Cocozza, Giovanna Antenucci, Giada Mascio, Umberto Bettarini, Alessandro Landolfi, Luca Iorio, Angelo Maffei, and Giuseppe Lembo
Hypertension 2009 54: 1028-1034. [Abstract] [Full Text] [PDF]